BioNexus Gene Lab Corp. (BGLC)
NASDAQ: BGLC · Real-Time Price · USD
0.2600
+0.0236 (9.98%)
At close: Apr 1, 2025, 4:00 PM
0.2555
-0.0045 (-1.75%)
After-hours: Apr 1, 2025, 7:50 PM EDT

BioNexus Gene Lab Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2016
Period Ending
Apr '25 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2016
Market Capitalization
59165365236-
Upgrade
Market Cap Growth
-48.07%-94.33%-54.75%54.35%--
Upgrade
Enterprise Value
13164363236-
Upgrade
Last Close Price
0.240.5311.4025.5627.60-
Upgrade
PE Ratio
---485.24215.96-
Upgrade
PS Ratio
0.450.9615.1027.2920.74-
Upgrade
PB Ratio
0.450.9724.7650.8035.47-
Upgrade
P/TBV Ratio
0.850.9724.7650.8035.47-
Upgrade
P/FCF Ratio
-331.6260792.571802.86-
Upgrade
P/OCF Ratio
-299.0739809.48427.52-
Upgrade
EV/Sales Ratio
0.120.3414.9727.1720.69-
Upgrade
EV/EBITDA Ratio
--316.52358.35-
Upgrade
EV/EBIT Ratio
--343.88415.74-
Upgrade
EV/FCF Ratio
-328.7460523.501798.19-
Upgrade
Debt / Equity Ratio
0.030.020.010.010.020.08
Upgrade
Debt / EBITDA Ratio
---0.070.19-
Upgrade
Debt / FCF Ratio
--0.1112.830.94-
Upgrade
Asset Turnover
0.830.971.191.362.010.09
Upgrade
Inventory Turnover
6.427.987.748.2316.346.21
Upgrade
Quick Ratio
3.994.242.522.392.0216.97
Upgrade
Current Ratio
4.974.933.013.072.3717.11
Upgrade
Return on Equity (ROE)
-9.87%-32.21%-5.14%10.86%28.11%-18.64%
Upgrade
Return on Assets (ROA)
-2.29%-12.68%-1.50%6.70%6.25%-11.95%
Upgrade
Return on Capital (ROIC)
-2.65%-15.45%-1.97%9.40%8.86%-12.24%
Upgrade
Return on Capital Employed (ROCE)
---14.60%8.40%-
Upgrade
Earnings Yield
-18.99%-28.08%-0.22%0.21%0.46%-
Upgrade
FCF Yield
-53.44%-15.50%0.30%0.00%0.06%-
Upgrade
Buyback Yield / Dilution
-18.10%-10.17%-0.99%-66.36%-19.16%-30.20%
Upgrade
Updated Nov 15, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q